Dear Madam/Sir,

Thank you very much for your email to Novartis regarding the Sandoz business in Belarus.

Sandoz is a global leader in generic and biosimilar medicines. Our company purpose is to help patients around the world access high-quality and affordable medicines. We are committed to driving access to medicines based on the strong belief that patients have a right to get the medicines they need at prices they can afford.

In Belarus, we support patients by providing medicines and information that benefit the local healthcare system and patients in need of medical treatments. We run select and seasonal advertisement to create awareness for our medicines and to help educate patients and healthcare professionals on potential treatment options.

All our advertisement activities strictly comply with all relevant international regulations and requirements.

We continue to carefully monitor developments in the country and keep evaluating the situation accordingly. Our first priority remains to ensure that the people in Belarus will be able to get the medicines they need, and we remain committed to supporting patients in the country.

Please reach out to us directly if you have any further questions.

Best regards

Arnaud Mahéas Michael Lermer

Head Sandoz Public Affairs Europe Head Sandoz Communications Europe